More articles from Volume 28, Issue 3, 2012
Childbirth with fetal pelvis presentatio: Challenge in modern obstetrics
Analysis of toxicity and tolerance of contrast agents in conventional, CT and MR
Trends in the incidence of germ cell testicular tumors (1976-2005)
Antioxidant enzyme activities in erythrocytes of healthy pregnant women, preeclamptic women and newborns
rEVIjaLNI rad Kontroverze skrininga gestacionog dijabetesa i uloga ultrasonografije kao alternativne metode skrininga
Article views
rEVIjaLNI rad Kontroverze skrininga gestacionog dijabetesa i uloga ultrasonografije kao alternativne metode skrininga
Milan Perovic
Published: 01.12.2011.
Biochemistry
Volume 28, Issue 3 (2012)
pp. 699-713;
Abstract
Keywords
References
1.
Kelly L, Evans L, Messenger D. Controversies around gestational diabetes: Controversies around gestational diabetes. Can Fam Physician. 2005;(5):688–95.
2.
Cunningham F. 2010;1104–26.
3.
O’sullivan Jb, Mahan C. Charles d, dandrow r: screening criteria for high-risk gestational diabetic patients. am j Obstet Gynecol. 1973;895–900.
4.
Berger H, Crane J, Farine, De La Ronde S, Keenan-Lindsay L, Leduc L, Reid G. Van aerde j; Maternal-Fetal Medicine Committee; Executive and Council for the society of Obstetricians and Gynaecologists of Canada. screening for Gestational diabetes Mellitus. jOGC. 2002;(11):894–912.
5.
Naylor Cd P, M, Chen. Farine d: selective screening for gestational diabetes mellitus. N Engl j Med. 1997;1591–6.
6.
american diabetes association: Gestational diabetes mellitus (Position statement). diabetes Care. 2004;(1):88–90.
7.
Metzger B, Dm C. Organizing Committee: summary and recommendations of the Fourth International Workshop. Gestational diabetes Mellitus diabetes Care. 1998;161-B167.
8.
Bjercke, Po, Tanbo T, Ertzeid G. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest. 2002;94–8.
9.
Mikola M, Hiilesmaa V, Halttunen M, L, Tiitinen. Obstetric outcome in women with polycystic ovarian syndrome. Hum reprod. 2001;226–9.
10.
Sattar N, Gaw P, Cj G, Ia. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre eclampsia. Br j Obstet Gynaecol. 1996;614–20.
11.
Piercy N, C, Eam G. do we know how to screen for gestational diabetes? Current practice in one regional health authority. Med. 1994;493–8.
12.
Jarrett Rj. should we screen for gestational diabetes? BMj. 1997;736–7.
13.
HaPO study Cooperative research Group. Hyperglycemia and adverse pregnancy outcomes. NEjM. 2008;1991–2002.
14.
Dr C. Management of gestational diabetes mellitus: a self fulfilling prophecy? jaMa. 1996;1199–200.
15.
Hornberger L. Maternal diabetes and the fetal heart. Heart. 2006;1019–21.
16.
Maulik. Umbilical arterial doppler sonography for fetal surveillance in pregnancies complicated by pregestational diabetes mellitus. Matern Fetal Neonatal Med. 2002;417–22.
17.
Towner D, Kjos Sl, Leung B, Montoro M, Xiang A, Mestman Jh. Congenital malformations in pregnancies complicated by NIddM. diabetes Care. 1995;1446–51.
18.
De Veciana M, Ca M, Ma M, Toohey Js T, Lien. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl j Med. 1995;1237–41.
19.
Engelgau M, Tj T, Herman W. screening for NIddM in nonpregnant adults: a review of principles, screening tests, and recommendations. diabetes Care. 1995;1606–17.
20.
Roberts Rn, Moohan Jm, Foo Rlk, Harley Jmg, Traub A, Hadden Dr. Fetal outcome in mothers with IGT in pregnancy. Med. 1993;438–43.
21.
Burden M, Burden, Jones G. Glucose tolerance during pregnancy in asian women. diabetes res Clin Prac. 1989;127–35.
22.
Caliskan E, Kayikcioglu F, Ozturk N. Koc s, Haberal a. a populationbased risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Obstet Gynecol scand. 2004;(6):524–30.
23.
Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio. Prevalence and risk factors for gestational diabetes assessed by universal screening. diabetes res Clin Pract. 2003;(2):131–7.
24.
Jensen Dm, Molsted-Pedersen L, Beck-Neilsen H, Westergaard Jg, Ovesen P, Damm P. screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. am j Obstet Gynecol. 2003;1383–8.
25.
Dixon Dr, Van Winter Jt N, Rl. Ogburn jr PL. Universal versus selective gestational diabetes screening: application of 1997 american diabetes association recommendations. am j Obstet Gynecol. 1999;(4):798–802.
26.
Griffith J C, Dl. Care of diabetes in pregnancy. Obstet Gynecol Clin N am. 2004;243–56.
27.
O’sullivan Jb, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. diabetes. 1964;278–85.
28.
Bonomo M, Gandini M, Mastropasqua, Begher C, Valentini U, Faden. Which cutoff level should be used in screening for glucose intolerance in pregnancy? am j Obstet Gynecol. 1998;(1):179–85.
29.
Coustan Dr, Widness J, Carpenter M, Rotondo L, Dc P. Oh W. should the fifty-gram one-hour glucose screening test for gestational diabetes be administered in the fasting or fed state? am j Obstet Gynecol. 1986;(5):1031–5.
30.
Carpenter M, Dr C. Criteria for screening tests for gestational diabetes. am j Obstet Gynecol. 1982;768–73.
31.
Berger H, Mathew. Counterpoint: selective screening for Gestational Mellitus. diabetes care. 2010;31–9.
32.
Blayo, Mandelbrot L. screening and diagnosis of gestational diabetes. diabetes Metab. 2004;575–80.
33.
Montagna M, Lippi G, Targher G, Fava C, Gs G. Glucose Challenge Test does not Predict Gestational diabetes Mellitus. Inter Med. 2008;1171–4.
34.
Gestational diabetes mellitus diabetes Care. 2008;(1):103–5.
35.
Gabbe Sg, Gregory Rp, Power M. Wiliams sB, schulkin j. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol. 2004;1229–34.
36.
Perkins. Perspectives in Gestational diabetes Mellitus: a review of screening, diagnosis, and Treatment. Clinical diabetes. 2007;57–62.
37.
Reece Ea, Leguizamon G, Wiznitzer. Gestational diabetes: The need for a common ground. Lancet. 2009;1789–96.
38.
Bruns De G, De, Maclaren N, Mcdonald Jm, Parrott M. Guidelines and recommendations for laboratory analysis n the diagnosis and management of diabetes mellitus. Clin Chem. 2002;436.
39.
National Collaborating Centre for Women’s and Children’s Health: antenatal Care: routine Care for the Healthy Pregnant Woman. London, royal College of Obstetricians and Gynaecology. 1993;
40.
Rahman N, Sheth F, K. Frequency of HLa genes and islet cell antibodies (ICa) and result of postpartum oral glucose tolerance tests (OGTT) in saudi arabian women with abnormal OGTT during pregnancy. diabetes res. 1990;(1):9–13.
41.
Perucchini D, Fischer U, Ga. Huch r, Huch a, Lehmann r: Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMj. 1999;812–5.
42.
Kousta E, Nj L, Penny, Ba M, Pj, Grenfell, et al. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. diabetes Care. 1999;933–7.
43.
Lind T. antenatal screening using random blood glucose values. diabetes. 1985;(2):17–20.
44.
Cousins L, Dattel B. Hollingsworth dr, Zettner a. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. am j Obstet Gynecol. 1984;455–60.
45.
Baker Jr C, Dj, Henlez P, Id. Fructosamine in diabetic pregnancy. Lancet. 1983;998–1000.
46.
Zorn T, Zuniga M, Madrid E, Tostes R, Fortes Z, Giachini F. san Martin s. Maternal diabetes affects cell proliferation in developing rat placenta. Histol Histopathol. 2011;1049–56.
47.
Thompson M, Vines, Wathen N, Harrington K. are placental lakes of any clinical significance. Placenta. 2002;(8):658–90.
48.
Merz E, Placenta W. Merz E, Bahlmann F Ultrasound in Obstetrics and Gynecology. 2005;388–404.
49.
Ohagwu C, Po, Ezeokeke U. Ugwu aC. relationship between placental thickness and growth parameters in normal Nigerian fetuses. african journal of Biotechnology. 2009;133–8.
50.
Gojnic M, Perovic M, Pervulov M, Ljubic. The effects of adjuvant Insulin therapy among pregnant women with IGT who failed to achieve the desired glycemia levels by diet and moderate physical activity. The journal of Maternal-Fetal & Neonatal Medicine. 2012;(10):2028–34.
51.
Story Cj. Borderline maintenance of erythrocyte 2,3-diphosphoglycerate concentrations in normoxic type 1 (insulin dependent) diabetic subjects. Clin sci (Lond). 1986;127–9.
52.
Saldeen P, Olofsson P. Laurini rN. structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur j Obstet Gynecol reprod Biol. 2002;136–42.
53.
Fadda G, Cherchi G, Nardelli P, Capobianco G, G. Placental and fetal pulsatility indices in gestational diabetes mellitus. j reprod Med. 2001;365–70.
54.
Ka T, Widness J, Clemons G, Voutilainen P, Mckinlay. amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol. 1987;710–6.
55.
Lolmede K, Durand De Saint Front V, Galitzky J, Lafontan M, Bouloumie. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442a adipocytes. Int j Obes relat Metab disord. 2003;1187–95.
56.
E, Dj H. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mrNa expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta. 1998;133–42.
57.
Hill Dj T, Gj, Caddell C, Kilkenny E, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. Clin Endocrinol Metab. 1995;2626–32.
58.
Teasdale F. Histomorphometry of the placenta of the diabetic women: class a diabetes mellitus. Placenta. 1981;241–51.
59.
Babawale M, Mayhew L, T, Mj L, Leach L. Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. diabetologia. 2000;1185–96.
60.
Jirkovska M, Kubinova L, Moravcova M, Krejci V, Karen. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. j Vasc res. 2002;268–78.
61.
Leach L, Mayhew T. Vasculogenesis and angiogenesis in the diabetic placenta. 2005;110–26.
62.
Desoye G. The human placenta in diabetic pregnancy. diabetes reviews. 1996;70–89.
63.
Laurini Rn, Visser Gha, Van Ballegooie E, Schoots C. Morphologycal findings in placentas of insulin dependant diabetic patients treated with continous subcutaneous insulin infusion (CsII). Placenta. 1987;153–65.
64.
Fox H. 1978;
65.
Green Dw, Mimouni F. Nucleated erythrocytes in healthy infants and infants of diabetic mothers. Pediatr. 1990;129–31.
66.
Evers I, Pgj N, Visser G. Placental pathology in Women with Type 1 diabetes and in a Control Group with Normal and Large-for-Gestational age Infants. Placenta. 2003;819–25.
67.
Perović M, Garalejić E, Gojnić M, Pantić B, Jović Bojović D, Fazlagić A I, Gardiner H. sensitivity and specificity of ultrasonography as a screening tool for gestational diabetes Mellitus. The journal of Maternal-Fetal & Neonatal Medicine. 2012;(8):1348–53.
68.
Gojnić M, Perović T, M, Garalejić B, Micić E, Maričić Z, et al. Prediction of fetal macrosomia and Gestational diabetes Mellitus with ultrasound parameters of glycemic control. Clinical and experimental obstetrics gynaecology. 2012;(4):512–6.
69.
Pat G, Berkowitz Rl, Hobbins J. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. am j Obstet Gynecol. 1979;915–22.
70.
Spirt Ba, Kagan E. sonography of the placenta semin Ultrasound. 1980;293–309.
71.
Hills D I, Gal. Tuck s, Baim r. distribution of placental grade in high risk gravidas. ajr. 1984;1011–3.
72.
Mr C, Rosenberg E, Bowie Jd T. Placental grading in the complicated or high-risk pregnancy. jUM. 1983;(7):297–301.
73.
Hiden U, Maier A, Bilban M, Ghaffari-Tabrizi N, Wadsack C, Lang I, Dohr G. Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy. diabetologia. 2006;123–31.
74.
Desoye G, Korgun E, Ghaffari-Tabrizi N, Cetin I, Hahn T. selective upregulation of placental glycogenin-2 in gestational diabetes is independent of hyperglycemia or hyperinsulinemia. j soc Gyn Invest. 2004;299.
75.
Hauguel-de Mouzon s. The Human Placenta in Gestational diabetes Mellitus diabetes. Care. 2007;(2):120–6.
76.
Hahn D, Blaschitz A, Korgun E, Lang I, Dohr G, G. From maternal glucose to fetal glycogen: expression of key regulators in the human placenta. Mol Hum reprod. 2001;1173–8.
77.
Radaelli T, Varastehpour, Catalano P. Hauguel-de Mouzon s. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. diabetes. 2003;2951–8.
78.
Xing Ay, Challier J, Lepercq J, Cauzac M, Mj C. Girard j, Hauguel-de Mouzon s. Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. Clin Endocrinol Metab. 1998;4097–101.
79.
Schneider H, Malek A. asymmetrical transport of glucose across the in vitro perfused human placenta. Placenta. 2003;27–33.
80.
Cr T, Eriksson G, Uj E. Effects of maternal diabetes on placental transfer of glucose in rats. diabetes. 1990;276–82.
81.
Goltzsch W, Bittner R B, Hj, Hofmann E. Effect of prenatal insulin and glucagon injection on the glycogen content of rat placenta and fetal liver. Biomed Biochim acta. 1987;619–22.
82.
Desoye G, Korgun E, Ghaffari-Tabrizi N, Hahn T. Is fetal macrosomia in adequately controlled diabetic women the result of a placental defect? a hypothesis. Matern Fetal Neonatal Med. 2002;258–61.
83.
Perović M. dijagnostički značaj ultrazvučnog skora u otkrivanju šećerne bolesti trudnica. doktorska disertacija. 2012;
84.
Zamlynski J, Bodzek P, Olejek, Manka G, Grettka K, Zamlynska K, et al. Correlation between amniotic fluid index (aFI) and glucose concentration in amniotic fluid, glycaemia, glycosylated haemoglobin concentration during normal pregnancy and pregnancy complicated by insulin-dependent diabetes mellitus. Med Wieku rozwoj. 2005;(3):407–16.
85.
Vink Jy P, Sh. Ghidini a, spong CY. amniotic fluid index and birth weight: is there a relationship in diabetics with poor glycemic control? american journal of Obstetrics and Gynecology. 2006;(3):848–50.
86.
Tr M. Creasy rK, resnik r, editors. Maternal fetal medicine, principles and practice. 1994;934.
87.
Chen R, Yogev Y, Ben-Haroush A, Jovanovic L, Hod M, Phillip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. Matern Fetal Neonatal Med. 2003;256–60.
88.
Pj L, Gj T, Mangez J. Effect of maternal glucose ingestion on fetal breathing and body movements in late pregnancy. Br j Obstet Gynecol. 1978;86–9.
89.
Badalian Ss, Fox H, Baxi L, Cr C. doppler ultrasound characteristics of fetal nasal flow in pregnancies complicated by diabetes mellitus. Matern Fetal Med. 2006;(4):206–10.
90.
Marsal K. Ultrasonic assessment of fetal activity. Clin Obstet Gynecol. 1983;541–63.
91.
Hs W, Copel J, Reece Ea. Cardiac growth of fetuses in diabetic mothers with good metabolic control. Pediatr. 1991;103–7.
92.
Ghandi Ja, Zhang X, Je M. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. am j Obstet Gynecol. 1995;1132–6.
93.
Breitweiser Ja, Meyer Ra M. Cardiac septal hypertrophy in hyperinsulinemic infants. Pediatr. 1980;535–9.
94.
Ta B, Kitzmiller Jl. Metabolic interaction of diabetes and pregnancy. annu rev Med. 1994;245–60.
95.
Ns M, Hop W, Jw W. Fetal cardiac function and septal thickness in diabetic pregnancy: a controlled observational and reproducibility study. Br j Obstetr Gynaecol. 1998;661–6.
96.
Veille Jc H, M. Fetal cardiac size in normal, intrauterine growth restricted, and diabetic pregnancies. am j Perinat. 1993;275–9.
97.
Fontes-Pedra Srf G. Fetal cardiomyopathies: etiologies, hemodynamic findings and clinical outcome. Circulation. 2002;585–91.
98.
Ld. Normal fetal cardiac measurements derived by cross-sectional echocardiography. Ultrasound in Obstetrics and Gynecology. 2003;(3):175–81.
99.
american Institute of Ultrasound in Medicine. aIUM practice guideline for the performance of obstetric ultrasound examinations. Ultrasound Med. 2010;157–66.
100.
Pongrojpaw C, D. Nomograms of the Fetal Heart between 16 and 39 Weeks of Gestation. j Med assoc Thai. 2008;1774–8.
101.
Nashaat E, Mansour G. Uncontrolled diabetes Mellitus and Fetal Heart. researcher. 2010;45–55.
102.
Kj V, Kanavi Roop Shekharappa, Venkatesh G, Veerananna H. Influence of Gestational diabetes Mellitus on Fetal growth parameters. Int j Biol Med res. 2011;(3):832–4.
103.
Evers I, De Valk H, Visser G. risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in Netherlands. BMj. 2004;915.
104.
Langer O, Rodriguez Da, Xenakis E, Mcfarland M, Berkus Md. Intensified versus conventional management of gestational diabetes. am j Obstet Gynecol. 1994;(4):1036–47.
105.
MaTErIa MEdICa. 2012;(3).
106.
Preece. New and future diabetes therapies: are they safe during pregnancy? j. Matern Fetal Neonatal Med. 2002;(6):365–75.
107.
Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol. 2000;283.
108.
Raychaudhuri K, Mj M. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol. 2000;190–4.
109.
Wong Sf, Chan F. Fetal Growth spurt and Pregestational diabetic Pregnancy. diabetes Care. 2002;1681–4.
110.
Vimercati, Greco P, Baldassarra P, Lestingi D, Laforgia N. Echographic measurement of subcutaneous tissue as fetal growth index. acta Biomed ateneo Parmense. 2000;(1):379–82.
111.
Vimercati M, Coluccia, Baldassarra L, Panella F, E. Fetal subcutaneous adipose tissue and gestational diabetes mellitus. Ultrasound in Obstetics and Gynecology. 2006;(4):468.
112.
Whitelaw a. subcutaneous fat in newborn infants of diabetic mothers: an indication of quality of diabetic control. Lancet. 1977;15–8.
113.
Greco P, Vimercati, Hyett M, Giorgino F, Loverro G. The ultrasound assessment of adipose tissue deposition in fetuses of “well controlled” insulin-dependent diabetic pregnancies. diabetic medicine. 2003;858–62.
114.
Jovanovic L. The role of continuous glucose monitoring in gestational diabetes mellitus. diabetes Technol Ther. 2000;(1):67–71.
115.
Evers I, De Valk H, Mol B, Ter Braak E, Visser G. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. diabetologia. 2002;1484–9.
116.
Kyne-Grzebalski D, Wood L, Marshall Sm T. Episodic hyperglycaemia in pregnant women with wellcontrolled Type 1 diabetes mellitus: a major potential factor underlying macrosomia. diabet Med. 1999;702–6.
117.
Nicolaides K. Turning the Pyramid of Prenatal Care. Fetal diagn Ther. 2011;183–96.
118.
Nicolides W, K. Prediction of preeclampsia from biophysical and biochemical markers at 11-13 weeks. Prenat diagn. 2011;66–74.
119.
Beta, Ventura W, Nicolaides K. Prediction of spontaneous preterm delivery from maternal factors and placental perfusion and function at 11-13 weeks. Prenat diagn. 2011;75–83.
120.
Nanda M, Nicolaides K. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat diagn. 2011;135–41.
121.
Maslowitz L, Jb. Hochner-Celnikier d. The validity of oral glucose tolerance test after 36 weeks’ gestation. Eur j Obstet Gynecol reprod Biol. 2006;19–24.
122.
Persson M, Winkvist, Mogren I. surprisingly low compliance to local guidelines for risk factor based screening for gestational diabetes mellitus -a population-based study. BMC Pregnancy and Childbirth. 2009;53.
123.
Lalić N. determinants of the inhibitory effect of glucose toxicity on growth hormone-induced improvement of insulin secretion from isolated human fetal islets. Transplant Proc. 1998;604–5.
124.
Grigorakis Si M, Beis C. Hormone parameters in gestational diabetes mellitus during the third trimester: high glucagon levels. Gynecol Obstet Invest. 2000;106–9.
125.
Beis C, Grigorakis S, Philippou G, M. Lack of suppression of plasma glucagon levels in late pregnancy persists postpartum only in women with previous gestational diabetes mellitus. autor za korespondenciju: Prim.dr sci.med Milan Perović Obilićev venac. 2005;31–5.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
